SEC v. Medsis International Inc. et al: Complaint

Complaint alleging securities fraud in which the individuals defendants “told prospective investors Medsis had entered into large lucrative contracts with Central and South American customers” in U. S. Securities and Exchange Commission v. Medsis International Inc., described as a Delaware-domiciled, Florida-based subsidiary of Medsis Medical Systems SA, of Panama; Joshua Dax Cabrera, of Miami, Florida, and Paul Hess, of Braintree, Massachusetts, at the U. S. District Court for the District of Massachusetts.

- You’re only seeing part of this content
  
  To view the entire article or download the document, subscribe today.
  
  – Offshore Courts: 29,000+ court cases (Bahamas, Bermuda, BVI, Cayman Islands)
  – Investigative Articles: 4,500+ in-depth articles, including fraud exposés
  – MLATs – Criminal: 1,400+ MLATs on global criminal investigations
  – Ch. 15 – Insolvencies: Monitored daily
  – Foreign Discovery: Applications for foreign discovery filed in the USA, monitored daily
  – Regulatory Actions: Global regulatory actions, fines, and bans, monitored daily
  – And More: Criminal indictments, extraditions, winding-up petitions, and more
  
  Unlimited access for less than $3/day.
  
  Cancel anytime.
  
  SUBSCRIBE
- SIGN IN
  
  Forgot your password?

Pages: 45

Date: August 19, 2021

Defendants/Respondents: Medsis International Inc., Joshua Dax Cabrera, Paul Hess

Plaintiffs/Applicants: U. S. Securities and Exchange Commission

Case Number: Xx Xx Xx

Topic: Investment

Allegation: Fraud

Topics

Panama Peru USA

[ 3 more... ] [ top 5 ]

Keywords

Joshua Dax Cabrera Medsis International Inc. Medsis Medical Systems Paul Hess U. S. Securities and Exchange Commission

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.